Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database Journal Article


Authors: Bickel, H.; Clauser, P.; Pinker, K.; Helbich, T.; Biondic, I.; Brkljacic, B.; Dietzel, M.; Ivanac, G.; Krug, B.; Moschetta, M.; Neuhaus, V.; Preidler, K.; Baltzer, P.
Article Title: Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database
Abstract: Objectives: To develop an intuitive and generally applicable system for the reporting, assessment, and documentation of ADC to complement standard BI-RADS criteria. Methods: This was a multicentric, retrospective analysis of 11 independently conducted institutional review board–approved studies from seven institutions performed between 2007 and 2019. Breast Apparent Diffusion coefficient (ADC-B) categories comprised ADC-B0 (ADC non-diagnostic), ADC-B1 (no enhancing lesion), and ADC-B2-5. The latter was defined by plotting ADC versus cumulative malignancy rates. Statistics comprised ANOVA with post hoc testing and ROC analysis. p values ≤ 0.05 were considered statistically significant. Results: A total of 1625 patients (age: 55.9 years (± 13.8)) with 1736 pathologically verified breast lesions were included. The mean ADC (× 10−3 mm2/s) differed significantly between benign (1.45, SD.40) and malignant lesions (.95, SD.39), and between invasive (.92, SD.22) and in situ carcinomas (1.18, SD.30) (p <.001). The following ADC-B categories were identified: ADC-B0—ADC cannot be assessed; ADC-B1—no contrast-enhancing lesion; ADC-B2—ADC ≥ 1.9 (cumulative malignancy rate < 0.1%); ADC-B3—ADC 1.5 to < 1.9 (0.1–1.7%); ADC-B4—ADC 1.0 to < 1.5 (10–24.5%); and ADC-B5—ADC < 1.0 (> 24.5%). At the latter threshold, a positive predictive value of 95.8% (95% CI 0.94–0.97) for invasive versus non-invasive breast carcinomas was reached. Conclusions: The breast apparent diffusion coefficient system (ADC-B) provides a simple and widely applicable categorization scheme for assessment, documentation, and reporting of apparent diffusion coefficient values in contrast-enhancing breast lesions on MRI. Clinical relevance statement: The ADC-B system, based on diverse MRI examinations, is clinically relevant for stratifying breast cancer risk via apparent diffusion coefficient measurements, and complements BI-RADS for improved clinical decision-making and patient outcomes. Key Points: • The breast apparent diffusion coefficient category system (ADC-B) is a simple tool for the assessment, documentation, and reporting of ADC values in contrast-enhancing breast lesions on MRI. • The categories comprise ADC-B0 for non-diagnostic examinations, ADC-B1 for examinations without an enhancing lesion, and ADC-B2-5 for enhancing lesions with an increasing malignancy rate. • The breast apparent diffusion coefficient category system may be used to complement BI-RADS in clinical decision-making. © 2023, The Author(s).
Keywords: adult; controlled study; middle aged; retrospective studies; major clinical study; clinical trial; cancer risk; nuclear magnetic resonance imaging; magnetic resonance imaging; sensitivity and specificity; classification; diagnosis, differential; breast; phyllodes tumor; differential diagnosis; pathology; diagnostic imaging; breast neoplasms; data base; retrospective study; multicenter study; breast tumor; breast carcinoma; contrast medium; contrast media; invasive carcinoma; medical documentation; mastitis; dynamic contrast-enhanced magnetic resonance imaging; diffusion weighted imaging; diffusion magnetic resonance imaging; predictive value; lobular carcinoma in situ; breast hyperplasia; breast papilloma; atypical ductal hyperplasia; diagnostic test accuracy study; fat necrosis; apparent diffusion coefficient; fibrocystic breast disease; breast imaging reporting and data system; invasive breast cancer; humans; human; female; article; benign breast tumor; ductal breast carcinoma in situ; invasive lobular breast carcinoma; papillary carcinoma of the breast; mucinous carcinoma of the breast
Journal Title: European Radiology
Volume: 33
Issue: 8
ISSN: 0938-7994
Publisher: Springer  
Date Published: 2023-08-01
Start Page: 5400
End Page: 5410
Language: English
DOI: 10.1007/s00330-023-09675-0
PUBMED: 37166495
PROVIDER: scopus
PMCID: PMC10326122
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors